Significance of the research This study clarifies the controversy regarding the effect of GLP-1 receptor agonists on body composition as a weight-management medication, and showcases how a genetic approach can enhance our understanding of how medications work
As consumers increasingly prefer high-protein, low-fat animal products, feed strategies are evolving toward metabolic enhancers rather than volume-based growth inputs
Microdosing was not part of those studies
After a year, the people receiving semaglutide had a 50 percent lower risk of AUD diagnosis and a 60 percent reduced risk of recurring AUD compared with the group that didnt receive the drug
S., Dostert, C., Nonnenmacher, Y., Cox, M., Binsfeld, C., Hao, Z., Brstle, A., Itsumi, M., Jger, C., Chen, Y., Pinkenburg, O., Camara, B., Ollert, M., Bindslev-Jensen, C., Vasiliou, V., Gorrini, C., Lang, P
Constipation and Slowed Bowel Motility One of the most common side effects of GLP-1 medications is constipation